Deltrasin, a commercially available PDE6D inhibitor, and additional derivative compounds have previously been reported to bind in PDE6D’s hydrophobic pocket and inhibit the growth of pancreatic cancer cell lines [23]. This evidence concerns the gene PDE6D and familial pancreatic carcinoma.